Low Level laser Therapy (LLLT) Cold Laser - THOR Laser

Do More With A THOR
Lots of happy THOR customer testimonials
NovoTHOR Whole Body Light Pod

Musculoskeletal Injuries

Musculoskeletal Injuries

What do these people have in common ?

Soft tissue injury and joint disorder rehabilitation with laser and LED photobiomodulation...

The most popular use of laser and LED photobiomodulation is the treatment of sports injuries and joint conditions. Many of the world's elite athletes use laser therapy to speed their recovery...Why?

  1. There is more published clinical and physiological evidence supporting the use of laser and LED photobiomodulation for soft tissue injuries and joint conditions than any electrotherapy modality as traditionally used by PT's / physiotherapists.

  2. It's considered the safest "electrotherapy" available by research experts.

  3. It's quick and simple to apply.

  4. Can be used immediately after injury, over pins, plates and bony prominences.

Clinical Research



OUR CUSTOMERS INCLUDE:
Our customers include: Harvard Medical School, Massachusetts General Hospital, British Army, RAF, Royal Navy, Team GB, Manchester United, MIT, Harvard School of Public Health, Cedars Sinai, City of Hope, USUHS
THOR Customers

THOR Photomedicine Ltd is an ISO 13485:2016 certified medical device company.

The THOR LX2.3 Photobiomodulation system has a medical CE mark (EC certificate). It is indicated for oral mucositis, tendinopathies, joint pain, neck pain and back pain for marketing in the UK, EU and Australia.

The THOR LX2.3 Photobiomodulation system is also FDA Cleared for marketing in the United States for: Temporary increase in local blood circulation, temporary relief of minor muscle and joint aches, pains and stiffness and relaxation of muscles; for muscle spasms, and minor pain and stiffness associated with arthritis.

Excluding the THOR LED Helmet, THOR LX2 and NovoTHOR systems are manufactured under conditions fulfilling the quality system requirements of Annex II, excluding (4), of the directive 93/42/EEC as amended and satisfy the applicable international harmonised standards.

Positive systematic reviews published by:

The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)

Appropriate regulatory clearance or approvals include:

Quality certificates